NOVO ACQUISITION OF NORDISK CREATES WORLDWIDE INSULIN BUSINESS APPROACHING $600 MIL., CHALLENGING LILLY FOR TOP SPOT; SYNERGY GAINED IN BIOTECH AREA

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".